8W84
HLA-DQ2.5-alpha2 gliadin peptide in complex with DQN0344AE02
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | SPRING-8 BEAMLINE BL45XU |
| Synchrotron site | SPring-8 |
| Beamline | BL45XU |
| Temperature [K] | 100 |
| Detector technology | PIXEL |
| Collection date | 2020-04-08 |
| Detector | DECTRIS PILATUS 6M |
| Wavelength(s) | 1.00000 |
| Spacegroup name | I 21 21 21 |
| Unit cell lengths | 82.860, 138.707, 201.928 |
| Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
| Resolution | 114.330 - 2.105 |
| R-factor | 0.2634 |
| Rwork | 0.260 |
| R-free | 0.32510 |
| Structure solution method | MOLECULAR REPLACEMENT |
| Starting model (for MR) | 7VG1 |
| RMSD bond length | 0.008 |
| RMSD bond angle | 1.010 |
| Data reduction software | XDS (Jan 31, 2020) |
| Data scaling software | Aimless (0.7.4) |
| Phasing software | PHASER |
| Refinement software | BUSTER (2.11.8) |
Data quality characteristics
| Overall | Inner shell | Outer shell | |
| Low resolution limit [Å] | 114.332 | 114.332 | 2.290 |
| High resolution limit [Å] | 2.105 | 7.046 | 2.105 |
| Rmerge | 0.078 | 0.030 | 1.421 |
| Rmeas | 0.083 | 0.032 | 1.516 |
| Rpim | 0.028 | 0.011 | 0.523 |
| Total number of observations | 354515 | 17025 | 16425 |
| Number of reflections | 39315 | 1965 | 1966 |
| <I/σ(I)> | 17.13 | 52.71 | 1.53 |
| Completeness [%] | 93.4 | 99.8 | 61.4 |
| Completeness (spherical) [%] | 58.1 | 99.8 | 13.2 |
| Completeness (ellipsoidal) [%] | 93.4 | 99.8 | 61.4 |
| Redundancy | 9.02 | 8.66 | 8.35 |
| CC(1/2) | 0.999 | 1.000 | 0.552 |
| Anomalous completeness (spherical) | 57.5 | 99.9 | 12.9 |
| Anomalous completeness | 93.3 | 99.9 | 61.7 |
| Anomalous redundancy | 4.7 | 4.9 | 4.3 |
| CC(ano) | -0.156 | -0.402 | 0.007 |
| |DANO|/σ(DANO) | 0.8 | 0.7 | 0.7 |
| Diffraction limits | Principal axes of ellipsoid fitted to diffraction cut-off surface |
| 2.105 Å | 1.000, 1.000, 1.000 |
| 2.126 Å | 0.000, 0.000, 0.000 |
| 3.384 Å | 0.000, 0.000, 0.000 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | VAPOR DIFFUSION, SITTING DROP | 4 | 293 | 80 mM di-Sodium malonate (pH4.0), 9.6 %w/v Polyethylene glycol 3,350, and 25 %v/v Ethylene glycol as cryoprotectant |






